-+ 0.00%
-+ 0.00%
-+ 0.00%

Citius Oncology Q1 EPS $(0.06) Misses $(0.04) Estimate, Sales $3.944M Miss $4.373M Estimate

Benzinga·02/13/2026 13:10:32
Listen to the news
Citius Oncology (NASDAQ:CTOR) reported quarterly losses of $(0.06) per share which missed the analyst consensus estimate of $(0.04) by 50 percent. This is a 33.33 percent increase over losses of $(0.09) per share from the same period last year. The company reported quarterly sales of $3.944 million which missed the analyst consensus estimate of $4.373 million by 9.81 percent.